Your browser doesn't support javascript.
loading
Choline deficiency-related multi-omics characteristics are susceptible factors for chemotherapy-induced thrombocytopenia.
Yao, Houshan; Xu, Huilin; Qiu, Shi; Chen, Jiani; Lin, Zeshuai; Zhu, Jiawei; Sun, Xiaomeng; Gao, Qianmin; Chen, Xintao; Xi, Chaowen; Huang, Doudou; Zhang, Feng; Gao, Shouhong; Wang, Zhipeng; Zhang, Jian; Liu, Xuan; Ren, Guoliang; Tao, Xia; Li, Mingming; Chen, Wansheng.
Afiliación
  • Yao H; Department of General Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
  • Xu H; Institutes of Biomedical Sciences, Fudan University, Shanghai 200032, China.
  • Qiu S; Traditional Chinese Medicine Resource and Technology Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Chen J; Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
  • Lin Z; Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China; Department of Biochemistry and Molecular Biology, Shanxi Medical University, Taiyuan, Shanxi 030001, China.
  • Zhu J; Traditional Chinese Medicine Resource and Technology Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Sun X; Research Institute, GloriousMed Clinical Laboratory Co., Ltd., Shanghai 201318, China.
  • Gao Q; Department of General Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
  • Chen X; Department of General Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
  • Xi C; Research Institute, GloriousMed Clinical Laboratory Co., Ltd., Shanghai 201318, China.
  • Huang D; Traditional Chinese Medicine Resource and Technology Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Zhang F; Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China; Shanghai Key Laboratory for Pharmaceutical Metabolite Research, Shanghai 200433, China.
  • Gao S; Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China; Shanghai Key Laboratory for Pharmaceutical Metabolite Research, Shanghai 200433, China.
  • Wang Z; Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
  • Zhang J; Department of General Surgery, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
  • Liu X; Department of Traditional Chinese Medicine, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China.
  • Ren G; Hualuo Biotech Co., Ltd., Shanghai 200000, China; Guangzhou Geneseiko Biomedical Technology Co., Ltd., Guangzhou 511466, China.
  • Tao X; Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China. Electronic address: taoxia@smmu.edu.cn.
  • Li M; Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China. Electronic address: limingming@smmu.edu.cn.
  • Chen W; Traditional Chinese Medicine Resource and Technology Center, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China; Department of Pharmacy, Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China; Shanghai Key Laboratory for Pharmaceutical Metabolite Rese
Pharmacol Res ; 178: 106155, 2022 04.
Article en En | MEDLINE | ID: mdl-35248699

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombocitopenia / Neoplasias Colorrectales / Deficiencia de Colina / Leucopenia / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trombocitopenia / Neoplasias Colorrectales / Deficiencia de Colina / Leucopenia / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos